P2RY2 and metabolic dysfunction-associated steatotic liver disease: In summary, P2Y2R deficiency improved insulin resistance, triglyceride accumulation, and hepatocellular injury by reducing hepatic lipogenesis and promoting mitochondrial FAO, thereby ameliorating NAFLD phenotype.